Wednesday, July 8, 2026

Patent directory · USPTO A61K / A61P

Patents matching “Takeda Pharmaceutical Company Limited”

1,022 pharma patents match "Takeda Pharmaceutical Company Limited" in our USPTO index (A61K/A61P) — applicant, grant date, expiration, and drug links.

Matches 1,022
Index total 30,257
Page 22 / 43

Quick answer

This filtered view shows 1,022 pharmaceutical patents matching "Takeda Pharmaceutical Company Limited" in our USPTO PatentsView index (CPC A61K/A61P). Search matches patent number, title, applicant, and CPC classification codes.

Patent results

1,022 results for “Takeda Pharmaceutical Company Limited” · 30,257 patents in full index Clear search

  1. US 9181249

    Substituted pyrido[3,4-b]pyrazines as GPR6 modulators

    Takeda Pharmaceutical Company Limited · Granted Nov 10, 2015 · Expires Nov 5, 2035

    granted
  2. US 9181255

    Fused heteroaromatic pyrrolidinones as SYK inhibitors

    Takeda Pharmaceutical Company Limited · Granted Nov 10, 2015 · Expires Nov 5, 2035

    granted
  3. US 9180122

    5- or 6-substituted 3-hydroxy-2 (1 H)-pyridinones as D-amino acid oxidase (DAAO) inhibitors in therapy of diseases such as schizophrenia, cognitive disorder and pain

    Takeda Pharmaceutical Company Limited · Granted Nov 10, 2015 · Expires Nov 5, 2035

    granted
  4. US 9181186

    Aromatic ring compound

    Takeda Pharmaceutical Company Limited · Granted Nov 10, 2015 · Expires Nov 5, 2035

    granted
  5. US 9173849

    Solid pharmaceutical composition

    Takeda Pharmaceutical Company Limited · Granted Nov 3, 2015 · Expires Oct 29, 2035

    granted
  6. US 9175037

    Neuromedin U derivative

    Takeda Pharmaceutical Company Limited · Granted Nov 3, 2015 · Expires Oct 29, 2035

    granted
  7. US 9169238

    Solid pharmaceutical composition

    Takeda Pharmaceutical Company Limited · Granted Oct 27, 2015 · Expires Oct 22, 2035

    granted
  8. US 9156837

    Heterocyclic compound

    Takeda Pharmaceutical Company Limited · Granted Oct 13, 2015 · Expires Oct 8, 2035

    granted
  9. US 9157069

    Method of producing pancreatic hormone-producing cells

    Takeda Pharmaceutical Company Limited · Granted Oct 13, 2015 · Expires Oct 8, 2035

    granted
  10. US 9156829

    Cycloalkyl and heterocycloalkyl compounds as orexin receptor antagonists

    Takeda Pharmaceutical Company Limited · Granted Oct 13, 2015 · Expires Oct 8, 2035

    granted
  11. US 9150588

    Substituted pyridazin-4(1H)-ones as phosphodiesterase 10A inhibitors

    Takeda Pharmaceutical Company Limited · Granted Oct 6, 2015 · Expires Oct 1, 2035

    granted
  12. US 9150591

    Heterocyclic compound and use thereof

    Takeda Pharmaceutical Company Limited · Granted Oct 6, 2015 · Expires Oct 1, 2035

    granted
  13. US 9149437

    Method for treatment of solid pharmaceutical preparation prior to printing and solid pharmaceutical preparation subjected to treatment prior to printing

    Takeda Pharmaceutical Company Limited · Granted Oct 6, 2015 · Expires Oct 1, 2035

    granted
  14. US 9145389

    Benzimidazole compound crystal

    Takeda Pharmaceutical Company Limited · Granted Sep 29, 2015 · Expires Sep 24, 2035

    granted
  15. US 9133129

    Bicyclic compound

    Takeda Pharmaceutical Company Limited · Granted Sep 15, 2015 · Expires Sep 10, 2035

    granted
  16. US 9120777

    Heterocyclic compound

    Takeda Pharmaceutical Company Limited · Granted Sep 1, 2015 · Expires Aug 27, 2035

    granted
  17. US 9120776

    Condensed heterocyclic compound

    Takeda Pharmaceutical Company Limited · Granted Sep 1, 2015 · Expires Aug 27, 2035

    granted
  18. US 9115139

    Pyrazinooxazepine derivatives

    Takeda Pharmaceutical Company Limited · Granted Aug 25, 2015 · Expires Aug 20, 2035

    granted
  19. US 9115136

    Fused ring compound and use thereof

    Takeda Pharmaceutical Company Limited · Granted Aug 25, 2015 · Expires Aug 20, 2035

    granted
  20. US 9108970

    Fused heteroaromatic pyrrolidinones

    Takeda Pharmaceutical Company Limited · Granted Aug 18, 2015 · Expires Aug 13, 2035

    granted
  21. US 9102666

    Methods and drug products for treating Alzheimer's disease

    Takeda Pharmaceutical Company Limited · Granted Aug 11, 2015 · Expires Aug 6, 2035

    granted
  22. US 9101660

    Solid preparation

    Takeda Pharmaceutical Company Limited · Granted Aug 11, 2015 · Expires Aug 6, 2035

    granted
  23. US 9102744

    Conjugated anti-CD38 antibodies

    Takeda Pharmaceutical Company Limited · Granted Aug 11, 2015 · Expires Aug 6, 2035

    granted
  24. US 9090586

    Heterocyclic compound

    Takeda Pharmaceutical Company Limited · Granted Jul 28, 2015 · Expires Jul 23, 2035

    granted